Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-026241
Filing Date
2024-11-06
Accepted
2024-11-06 16:30:07
Documents
1
Period of Report
2024-11-05

Document Format Files

Seq Description Document Type Size
1 form4-11062024_041101.html 4  
1 form4-11062024_041101.xml 4 9135
  Complete submission text file 0001415889-24-026241.txt   10659
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O UNITED THERAPEUTICS CORPORTION 1735 CONNECTICUT AVE. NW WASHINGTON DC 20009
Business Address
Giltner Richard (Reporting) CIK: 0001460472 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 241431503